Iradimed (NASDAQ:IRMD) Updates Q4 2024 Earnings Guidance

Iradimed (NASDAQ:IRMD) updated its fourth quarter 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 0.420-0.450 for the period, compared to the consensus earnings per share estimate of 0.400. The company issued revenue guidance of $18.8 million-$19.2 million, compared to the consensus revenue estimate of $19.3 million. Iradimed also updated its FY 2024 guidance to 1.640-1.670 EPS.

Analyst Upgrades and Downgrades

Separately, Roth Mkm lowered their target price on Iradimed from $65.00 to $60.00 and set a “buy” rating for the company in a research note on Friday, August 2nd.

Iradimed Stock Performance

Shares of Iradimed stock traded down $0.97 during mid-day trading on Friday, hitting $48.30. 32,944 shares of the stock were exchanged, compared to its average volume of 28,110. Iradimed has a 12 month low of $39.24 and a 12 month high of $53.99. The company has a 50-day simple moving average of $48.98 and a 200 day simple moving average of $45.56. The company has a market capitalization of $611.96 million, a P/E ratio of 33.08 and a beta of 0.79.

Iradimed (NASDAQ:IRMD) last announced its quarterly earnings data on Thursday, August 1st. The medical equipment provider reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.33 by $0.05. Iradimed had a return on equity of 24.59% and a net margin of 26.12%. The company had revenue of $17.93 million for the quarter, compared to analysts’ expectations of $17.70 million. During the same period last year, the firm posted $0.33 EPS. Analysts predict that Iradimed will post 1.47 EPS for the current year.

Iradimed Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, November 25th. Stockholders of record on Friday, November 15th will be issued a dividend of $0.15 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $0.60 annualized dividend and a dividend yield of 1.24%. Iradimed’s payout ratio is 41.10%.

About Iradimed

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.